Outcomes of cardiac surgeries following COVID-19 infection
Keywords:
COVID-19, Cardiac Surgery, Euroscore II, Triple Vessel Disease, CABGAbstract
Background: Worldwide, cardiac surgery has been significantly impacted by the COVID-19 pandemic infection. In the event of respiratory tract involvement, COVID-19 may be fatal and may serve as a significant contraindication to surgery. Our objective was to investigate the safety and outcomes of patients who underwent cardiac surgeries subsequent to their COVID-19 infection. Methods: This retrospective observational study was carried out on 22 patients undergoing elective or urgent open-heart surgery following COVID-19 infection. Results: 9 patients (40.91%) were extubated within 24 hours of surgery, 6 patients (27.27%) were extubated on the first postoperative day, and 3 patients (13.64%) were extubated on the second postoperative day. Regarding the postoperative complications, 6 (27.27%) patients required NIV with a mean ± SD of duration 6 ± 2.37 days (range 3-9 days), and 5 (22.73%) developed respiratory failure, 2 (9.09%) developed heart failure, 1 (4.55%) patient experienced AKI on pre-existing CKD, and 1 (4.55%) patient developed dilated cardiomyopathy was presenting with CAD + VHD. 3 (13.64%) patients needed inotropes, one of them developed dilated cardiomyopathy and the other two developed heart failure.
Downloads
References
Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17:259-60. DOI: https://doi.org/10.1038/s41569-020-0360-5
Lei S, Jiang F, Su W, Chen C, Chen J, Mei W, et al. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine. 2020;21:100331. DOI: https://doi.org/10.1016/j.eclinm.2020.100331
Cai Y, Hao Z, Gao Y, Ping W, Wang Q, Peng S, et al. Coronavirus Disease 2019 in the Perioperative Period of Lung Resection: A Brief Report From a Single Thoracic Surgery Department in Wuhan, People's Republic of China. J Thorac Oncol. 2020;15:1065-72. DOI: https://doi.org/10.1016/j.jtho.2020.04.003
Haft JW, Atluri P, Ailawadi G, Engelman DT, Grant MC, Hassan A, et al. Adult cardiac surgery during the COVID-19 pandemic: A tiered patient triage guidance statement. J Thorac Cardiovasc Surg. 2020;160:452-5. DOI: https://doi.org/10.1016/j.jtcvs.2020.04.011
Fudulu DP, Angelini GD. Cardiac surgery in the time of the coronavirus. J Card Surg. 2020;35:1177-9. DOI: https://doi.org/10.1111/jocs.14580
Fukuhara S, Rosati CM, El-Dalati S. Acute Type A Aortic Dissection During the COVID-19 Outbreak. Ann Thorac Surg. 2020;110:e405-e7. DOI: https://doi.org/10.1016/j.athoracsur.2020.04.008
Sanders J, Akowuah E, Cooper J, Kirmani BH, Kanani M, Acharya M, et al. Cardiac surgery outcome during the COVID-19 pandemic: a retrospective review of the early experience in nine UK centres. J Cardiothorac Surg. 2021;16:43. DOI: https://doi.org/10.1186/s13019-021-01424-y
COVIDSurg Collaborative & GlobalSurg Collaborativ. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. Anaesthesia. 2021;76:748-58. DOI: https://doi.org/10.1111/anae.15458
El-Boghdadly K, Cook TM, Goodacre T, Kua J, Blake L, Denmark S, et al. SARS-CoV-2 infection, COVID-19 and timing of elective surgery: A multidisciplinary consensus statement on behalf of the Association of Anaesthetists, the Centre for Peri-operative Care, the Federation of Surgical Specialty Associations, the Royal College of Anaesthetists and the Royal College of Surgeons of England. Anaesthesia. 2021;76:940-6. DOI: https://doi.org/10.1111/anae.15464
Hirji SA, Zogg CK, Nguyen TC. Commentary: To operate or wait? Contextualizing early outcomes of cardiac surgery in COVID-19-positive patients. J Thorac Cardiovasc Surg. 2021;162:e373-e4. DOI: https://doi.org/10.1016/j.jtcvs.2021.04.059
Cardiothoracic Interdisciplinary Research Network and COVIDSurg Collaborative. Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study. J Thorac Cardiovasc Surg. 2021;162:355-72. DOI: https://doi.org/10.1016/j.jtcvs.2021.03.091
Rescigno G, Firstenberg M, Rudez I, Uddin M, Nagarajan K, Nikolaidis N. A Case of Postoperative Covid-19 Infection After Cardiac Surgery: Lessons Learned. Heart Surg Forum. 2020;23:E231-e3. DOI: https://doi.org/10.1532/hsf.3011
Yates MT, Balmforth D, Lopez-Marco A, Uppal R, Oo AY. Outcomes of patients diagnosed with COVID-19 in the early postoperative period following cardiac surgery. Interact Cardiovasc Thorac Surg. 2020;31:483-5. DOI: https://doi.org/10.1093/icvts/ivaa143
Peng S, Huang L, Zhao B, Zhou S, Braithwaite I, Zhang N, et al. Clinical course of coronavirus disease 2019 in 11 patients after thoracic surgery and challenges in diagnosis. J Thorac Cardiovasc Surg. 2020;160:585-92.e2. DOI: https://doi.org/10.1016/j.jtcvs.2020.04.005
Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601-15. DOI: https://doi.org/10.1038/s41591-021-01283-z
Roffi M, Guagliumi G, Ibanez B. The Obstacle Course of Reperfusion for ST-Segment-Elevation Myocardial Infarction in the COVID-19 Pandemic. Circulation. 2020;141:1951-3. DOI: https://doi.org/10.1161/CIRCULATIONAHA.120.047523
Squiccimarro E, Labriola C, Malvindi PG, Margari V, Guida P, Visicchio G, et al. Prevalence and Clinical Impact of Systemic Inflammatory Reaction After Cardiac Surgery. J Cardiothorac Vasc Anesth. 2019;33:1682-90. DOI: https://doi.org/10.1053/j.jvca.2019.01.043
Sagris M, Theofilis P, Antonopoulos AS, Tsioufis C, Oikonomou E, Antoniades C, et al. Inflammatory Mechanisms in COVID-19 and Atherosclerosis: Current Pharmaceutical Perspectives. Int J Mol Sci. 2021;22. DOI: https://doi.org/10.3390/ijms22126607
Groeneveld GH, van Paassen J, van Dissel JT, Arbous MS. Influenza Season and ARDS after Cardiac Surgery. N Engl J Med. 2018;378:772-3. DOI: https://doi.org/10.1056/NEJMc1712727
Published
How to Cite
Issue
Section
Copyright (c) 2021 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
